The Psychedelics Newsletter, Issue 97

The Psychedelics Newsletter, Issue 97

No alt text provided for this image

EXCLUSIVE: Angela Allbee, Oregon Psilocybin Services Section Manager

PSYCH spoke with Angela Allbee, Oregon Psilocybin Services Section Manager at Oregon Health Authority, for The Psychedelics as Medicine Report: Fourth Edition.

While no prescription or referral is necessary, a client will be required to complete a preparation session with a licensed facilitator before participating in an administration session.

The client will only access psilocybin at a licensed service centre during an administration session in the presence of a licensed facilitator. An optional integration session will be offered to a client after the administration session.

READ MORE

No alt text provided for this image

PSILOCYBIN THERAPY VERSUS ESCITALOPRAM

In a study of patients with major depressive disorder, psilocybin therapy was better than escitalopram in reducing ruminative thinking.

READ MORE

No alt text provided for this image

IS THE PSYCHEDELIC THERAPY BUBBLE ABOUT TO BURST?

As share prices recover across the board, WIRED examines over expectations in psychedelic healthcare and the market’s future.?

READ MORE

BUSINESS AND INVESTMENT

SCIENCE AND RESEARCH

No alt text provided for this image
No alt text provided for this image

Partnership opportunities are now available?for?The Psychedelics as Medicine Report?

With over 60,000 downloads,?the industry?leading publication contains proprietary data that enables?regulators, researchers and investors to make informed decisions.

Previous partners include COMPASS Pathways, Cybin and Filament Health.

To be included in the fourth edition and to discuss future events, please contact?[email protected]

REGULATION AND LEGISLATION

ARTICLES OF INTEREST

要查看或添加评论,请登录

PSYCH?的更多文章

社区洞察

其他会员也浏览了